Live feed
Filing
SC 13G
SC 13G0001104659-16-137834·DMK PHARMACEUTICALS Corp
Schedule 13G ownership disclosure
Adamis Pharmaceuticals Corp
Security class unavailable · CUSIP: 00547W208
Event date: 2016-07-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,150,000
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-137834
- Form type
- SC 13G
- Filer
- DMK PHARMACEUTICALS Corp
- CIK
- CIK 887247
- Filed
- Aug 08, 2016
- Reporting period
- Jul 29, 2016
- Description
- Schedule 13G beneficial ownership